Genocea Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Genocea Biosciences

28/10/2021 14:34

* Genocea Biosciences Inc  GNCA.OQ  reported a quarterly
adjusted loss of 5 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 20 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Genocea Biosciences Inc's reported EPS for the quarter was a
loss of 5 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Genocea Biosciences Inc shares had fallen by 13.0% this
quarter and lost 31.0% so far this year.
* The company reported a quarterly loss of $3.62 million.
* Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated October 28 at 01:33 p.m.
 ​All figures in US dollars unless otherwise stated